Table 1.

Demographic and clinical characteristics of study subjects

Variables	Asthma patients (n = 8)
Age, years, mean ± SD	49.12 ± 16.63
Male, no. (%)	3 (37.5)
BMI, kg/m2, mean ± SD	21.92 ± 1.87
Rhinosinusitis, no. (%)	5 (62.5)
ICS dosea, μg.day-1, mean ± SD	407.5 ± 239.56
FEV1 (% predicted), mean ± SD	87.81 ± 15.39
FEV1/FVC (%), mean ± SD	73.66 ± 10.93
ACQ7 score, mean ± SD	0.625 ± 0.42
Percentage of eosinophils, mean ± SD	3.18 ± 1.57
Blood IgE (IU/ml)	166.56 ± 114.80
Duration of asthma, years, mean ± SD	9.82 ± 19.57
Atopic, no. (%)	4 (50)

ICS dose was expressed as beclomethasone propionate equivalent dose.